|
|
||||||||
From the University of Rochester Medical Center, Departments of Neurology (Drs. Schwid, Thornton, Goodman, and McDermott, and S. Pandya, K. Manzur, and M. Petrie) and Biostatistics (Dr. McDermott), Rochester, NY; and the University of Wisconsin Medical Center, Department of Neurology (Dr. Sanjak), Madison, WI.
Address correspondence and reprint requests to Dr. Steven R. Schwid, University of Rochester Medical Center, 601 Elmwood Avenue, Box 605, Rochester, NY 14642.
OBJECTIVE: To determine the testretest reliability of strength and fatigue measurements in patients with MS and in healthy control subjects, and to examine associations among motor fatigue, strength, and ambulatory impairment in MS patients.
BACKGROUND: Motor fatigue, defined as the loss of the maximal capacity to generate force during exercise, and weakness are common in patients with MS. Method: Twenty ambulatory MS patients and 20 age- and sex-matched healthy control subjects participated in the study. Testretest reliability was assessed in two identical testing sessions, separated by 3 to 5 days. Maximal voluntary isometric strength was determined by fixed myometry of seven muscle groups on each side. Motor fatigue was assessed using three exercise protocols: sustained maximal contractions (static fatigue), repetitive maximal contractions, and walking as far as 500 m. Four analysis models for static fatigue were examined for their testretest reliability and their ability to discriminate between normal fatigue and pathologic fatigue from MS.
RESULTS: Testretest reliability in MS patients was excellent for isometric strength and very good for static fatigue. Testretest reliability was lower for exercise protocols that involved repetitive contractions or ambulation. Compared with healthy control subjects, MS patients were weak in lower extremity muscles, but upper extremity strength was relatively preserved. Fatigue was greater in MS patients, even in muscles that were not clearly weak. There were no significant associations between strength and fatigue in any of the muscles tested. A fatigue analysis model based on the area under the force-versus-time curve gave the best combination of reliability and sensitivity to detect differences between MS patients and healthy control subjects.
CONCLUSIONS: Strength and motor fatigue can be measured reliably in patients with MS. MS patients experience more fatigue than healthy control subjects during sustained contractions, repetitive contractions, and ambulation. Motor fatigue appears to be distinct from weakness because the degree of fatigue was not associated with the degree of weakness in individual muscles. Quantitative assessment of strength and fatigue may be useful to monitor changes in motor function over time in MS patients.
Key words: MSFatigueStrengthWeaknessMotor dysfunctionMyometry.
This article has been cited by other articles:
![]() |
B. H. Dobkin Fatigue Versus Activity-Dependent Fatigability in Patients With Central or Peripheral Motor Impairments Neurorehabil Neural Repair, April 1, 2008; 22(2): 105 - 110. [Abstract] [PDF] |
||||
![]() |
U. Dalgas, E. Stenager, and T. Ingemann-Hansen Review: Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training Multiple Sclerosis, January 1, 2008; 14(1): 35 - 53. [Abstract] [PDF] |
||||
![]() |
A.D. Goodman, J.A. Cohen, A. Cross, T. Vollmer, M. Rizzo, R. Cohen, L. Marinucci, and A.R. Blight Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study Multiple Sclerosis, April 1, 2007; 13(3): 357 - 368. [Abstract] [PDF] |
||||
![]() |
L. Krupp Editorial Multiple Sclerosis, August 1, 2006; 12(4): 367 - 368. [PDF] |
||||
![]() |
D. M. Wingerchuk, E. E. Benarroch, P. C. O'Brien, B. M. Keegan, C. F. Lucchinetti, J. H. Noseworthy, B. G. Weinshenker, and M. Rodriguez A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis Neurology, April 12, 2005; 64(7): 1267 - 1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Romberg, A. Virtanen, J. Ruutiainen, S. Aunola, S.-L. Karppi, M. Vaara, J. Surakka, T. Pohjolainen, and A. Seppanen Effects of a 6-month exercise program on patients with multiple sclerosis: A randomized study Neurology, December 14, 2004; 63(11): 2034 - 2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Rose, M. K. Sharief, J. Priddin, V. Nikolaou, L. Hull, C. Unwin, R. Ajmal-Ali, R. A. Sherwood, A. Spellman, A. David, et al. Evaluation of neuromuscular symptoms in UK Gulf War veterans: A controlled study Neurology, November 9, 2004; 63(9): 1681 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Surakka, A. Romberg, J. Ruutiainen, S. Aunola, A. Virtanen, S.-L. Karppi, and K. Maentaka Effects of aerobic and strength exercise on motor fatigue in men and women with multiple sclerosis: a randomized controlled trial Clinical Rehabilitation, July 1, 2004; 18(7): 737 - 746. [Abstract] [PDF] |
||||
![]() |
J. Surakka, A. Romberg, J. Ruutiainen, A. Virtanen, S. Aunola, and K. Maentaka Assessment of muscle strength and motor fatigue with a knee dynamometer in subjects with multiple sclerosis: a new fatigue index Clinical Rehabilitation, June 1, 2004; 18(6): 652 - 659. [Abstract] [PDF] |
||||
![]() |
S. R Schwid, C. M Tyler, E. A Scheid, A. Weinstein, A. D Goodman, and M. P McDermott Cognitive fatigue during a test requiring sustained attention: a pilot study Multiple Sclerosis, October 1, 2003; 9(5): 503 - 508. [Abstract] [PDF] |
||||
![]() |
R. Bakshi Fatigue associated with multiple sclerosis: diagnosis, impact and management Multiple Sclerosis, June 1, 2003; 9(3): 219 - 227. [Abstract] [PDF] |
||||
![]() |
J. H. Noseworthy, P. C. O'Brien, B. G. Weinshenker, J. A. Weis, T. M. Petterson, B. J. Erickson, A. J. Windebank, J. P. Whisnant, K. A. Stolp-Smith, C. M. Harper Jr., et al. IV immunoglobulin does not reverse established weakness in MS: A double-blind, placebo-controlled trial Neurology, October 24, 2000; 55(8): 1135 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Krupp and L. E. Elkins Fatigue and declines in cognitive functioning in multiple sclerosis Neurology, October 10, 2000; 55(7): 934 - 939. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |